{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:46:50Z","timestamp":1759837610450,"version":"3.37.3"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11845-019-02106-4","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T08:33:31Z","timestamp":1571646811000},"page":"557-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acceptability and accuracy of oral fluid drug testing for patients on methadone maintenance"],"prefix":"10.1007","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8450-186X","authenticated-orcid":false,"given":"Michael Edmund","family":"O\u2019Callaghan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liam","family":"Regan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmett","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brid","family":"Hollywood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fergus","family":"O\u2019Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darach","family":"O\u2019Ciardha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"2106_CR1","unstructured":"Health Service Executive (HSE), Ireland. 2017. Clinical guidelines for opioid substitution treatment. Available at: \nhttps:\/\/www.hse.ie\/eng\/services\/publications\/primary\/clinical-guidelines-for-opioid-substitution-treatment.pdf\n\n (Accessed 14\/03\/2019)"},{"key":"2106_CR2","unstructured":"Health Service Executive (HSE), Ireland. 2014. Clinical guidelines for opioid substitution treatment. Available at: \nhttps:\/\/www.hse.ie\/eng\/services\/publications\/primary\/clinical-guidelines-for-opioid-substitution-treatment-ost-.html\n\n (Accessed 20\/04\/2018)"},{"key":"2106_CR3","unstructured":"Farrell M & Barry J. Health Service Executive Social Inclusion Unit, HSE, Dublin, Ireland (2010). The introduction of the opioid treatment protocol."},{"key":"2106_CR4","doi-asserted-by":"crossref","unstructured":"Magura S, Kang SY. National Development and Research Institutes, Inc., New York, NY 10013, USA. Subst Use Misuse. 1996 Jul;31(9):1131-53. Validity of self-reported drug use in high risk populations: a meta-analytical review.","DOI":"10.3109\/10826089609063969"},{"key":"2106_CR5","unstructured":"Ontario Health Technology Assessment Series. 2006; 6(21): 1\u201354. Optimum methadone compliance testing - an evidence-based analysis health quality."},{"issue":"2","key":"2106_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","volume":"26","author":"AG Verstraete","year":"2004","unstructured":"Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Therapeutic Drug Monitoring 26(2):200\u2013205","journal-title":"Therapeutic Drug Monitoring"},{"key":"2106_CR7","unstructured":"Health Research Board (HRB) National drug-related deaths index 2004 to 2016 Data. Available at: \nhttps:\/\/www.drugsandalcohol.ie\/30174\/13\/National_Drug-Related_Deaths_Index_2004_to_2016_data.pdf\n\n (Accessed 22\/3\/2019)"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-019-02106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-019-02106-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-019-02106-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T23:17:43Z","timestamp":1603149463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-019-02106-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s11845-019-02106-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"19 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the study was obtained from the Trinity College Dublin\/Health Service Executive (TCD\/HSE) GP Training Scheme Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Point-of-care testing:Testing for drug metabolites at the point-of-care (i.e., result available immediately such that it can impact on current consultation)","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Glossary"}}]}}